<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:chebi fb="1" ids="18421">Superoxide</z:chebi> has been implicated in the pathogenesis of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase, a major source of <z:chebi fb="1" ids="18421">superoxide</z:chebi> generation in neutrophils and the vascular system, plays a critical role in ischemic injury and atherogenesis </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, an association between the C242T polymorphism of p22 PHOX, an essential component of <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase, and <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> (CAD) has been reported in several studies </plain></SENT>
<SENT sid="3" pm="."><plain>To investigate the relationship between the C242T polymorphism of p22 PHOX and ischemic cerebrovascular disease (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>), we conducted a case-control study </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: We recruited 226 CVD patients (atherothrombotic <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">infarction, lacunar</z:e> infarction, and <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo>) and 301 control subjects and analyzed C242T polymorphism of p22 PHOX by detection of restriction fragment length polymorphism </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The TC+TT genotype frequencies in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> group and control group were 21.7% and 13.3%, respectively, and the prevalence of the TC+TT genotype was significantly higher in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> patients (chi(2)=6.477, P=0.01, OR 1.81, 95% CI 1.15 to 2.86) </plain></SENT>
<SENT sid="6" pm="."><plain>Analysis by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> subtypes showed that the OR for the TC+TT genotype was higher in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> patients with atherothrombotic infarction than in those with <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> and <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The C242T polymorphism of the <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase p22 PHOX gene is a novel pathogenetic risk factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
</text></document>